22470 Results

People

  1. Ladanyi
    Ladanyi
  2. Antonescu
    Antonescu
  3. Offit
    Offit
  4. Solit
    Solit
  5. Levine
    Levine
  6. Berger
    Berger
  7. O'Reilly
    O'Reilly
  8. Cheung
    Cheung
  9. Reis-Filho
    Reis-Filho
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. GSK Faculty (22470)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10530)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)
  7. Human Oncology and Pathogenesis Program (5699)
  8. Center for Hematologic Malignancies (5360)
  9. Center for Molecular Imaging and Biotechnology (5298)
  10. Department of Pathology and Laboratory Medicine (4773)
  1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7078)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22470)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10530)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (298)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GBM AGILE platform trial for newly diagnosed and recurrent GBM: Results of first experimental arm, regorafenib
    Meeting Abstract

    Lassman, A.; Alexander, B.; Berry, D.; Buxton, M.; Cavenee, W.; Colman, H.; De Groot, J.; Ellingson, B.; Gordon, G.; Hyddmark, E. M. V.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (CTDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • CXCL1 mediates leptomeningeal metastasis growth
    Meeting Abstract

    Osman, A.; Remsik, J.; Wijetunga, A.; Snyder, J.; Manoranjan, B.; Nobre, A.; Freret, M.; Guber, D.; Chabot, K.; Piedrafita-Ortiz, S.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Global expansion of GBM AGILE: A phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Weller, M.; Berry, D.; Blondin, N.; Boulmay, B.; Buxton, M.; Chinot, O.; Colman, H.; de la Fuente, M.; de Groot, J.; Drappatz, J.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Perry, J. R.; Cloughesy, T.; Berry, D. A.; Buxton, M. B.; Colman, H.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Mellinghoff, I. K.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • CRISPR-Cas9 genetic targeting of metastatic pancreatic cancer
    Meeting Abstract

    Bowland, K.; Lai, J.; Teh, S. S. K.; Bennett, A.; Skaist, A.; Zhang, Y.; Thompson, E.; Wheelan, S. J.; Hruban, R. H.; Karchin, R.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • CAR T-cell-derived TNF drives cytokine release syndrome and enhances M1 macrophage differentiation
    Meeting Abstract

    Lindenbergh, P. L.; Giavridis, T.; Vivier, O.; Lopez, M.; Dobrin, A.; Sadelain, M.
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Loss of heterozygosity is low for specific HLA alleles in cancer patients with driver mutations
    Meeting Abstract

    Roy, C.; Sewastianik, T.; Halvey, P.; Montesion, M.; Jindal, A.; Vallaster, M.; Lam, H.; Garrity, S.; Shapiro, G.; Klebanoff, C. A.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • THRIVE(TM) non-viral targeted transgene knock-in platform generates specific and potent TCR T cell products for the treatment of solid cancers
    Meeting Abstract

    Narayan, S.; Swanson, N.; Drain, A.; Gareau, K.; Rouillard, N.; Liang, J.; Liu, H. W.; Brown, L.; Lamothe, R.; Greenberg, P. D.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson's disease: Results up to 18 months from a phase 1 study
    Meeting Abstract

    Henchcliffe, C.; Sarva, H.; Lozano, A.; Fasano, A.; Kalia, S.; Yu, K. K. H.; Brennan, C.; Stemple, W.; Abid, N.; Yountz, M.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save